Submitted on Jul 10, 2012
Late last week, as part of the larger Food and Drug Administration Safety and Innovation Act, the Senate approved a bill to combat the use and abuse of synthetic drugs. The bill is now awaiting the President's signature. Reports indicate that DEA officials have anonymously complained that the bill does not cover all of the stimulants that it thought it should. The bill bans mephedrone, MDPV, cannabimimetic agents including 15 that are named specifically, and nine synthetic psychedelics in the 2C family. Read the full text of the bill. (Scroll down to Subpart D at the end of the document).